Cargando…

Immune response to COVID-19 vaccination in a population with and without a previous SARS-CoV-2 infection

PURPOSE: To evaluate IgG production in a group of vaccinated and unvaccinated subjects previously infected, or not, with SARS-CoV-2. METHODS: A total of 316 subjects were enrolled at different times after vaccination and/or infection. IgG against target S1 subunit of the spike protein of SARS-COV-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duro, Mary, Almeida, Cristina, Duro, Inês, Sarmento, Amélia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177345/ https://www.ncbi.nlm.nih.gov/pubmed/35676470 http://dx.doi.org/10.1007/s11845-022-03044-4

Ejemplares similares

Pre-vaccination immune response to COVID-19 in a population in Northeast Portugal
por: Duro, Mary, et al.
Publicado: (2021)

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
por: Blom, Kim, et al.
Publicado: (2022)

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
por: Suryawanshi, Rahul K., et al.
Publicado: (2022)

B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19
por: Zollner, Andreas, et al.
Publicado: (2021)

SARS-CoV-2 vaccines: anamnestic response in previously infected recipients
por: Purushotham, Jyothi N., et al.
Publicado: (2021)

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
por: Pérez-Alós, Laura, et al.
Publicado: (2023)

Acute exercise and immune response in previously SARS CoV-2 infection
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Assessment of humoral immune response to two mRNA SARS‐CoV‐2 vaccines (Moderna and Pfizer) in healthcare workers fully vaccinated with and without a history of previous infection
por: Serrano, Laura, et al.
Publicado: (2022)

Vaccine against SARS-CoV-2 in previously infected health care workers
por: Parisi, Saverio Giuseppe
Publicado: (2021)

Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees
por: Kojima, N., et al.
Publicado: (2022)

The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
por: Boaventura, Viviane S, et al.
Publicado: (2023)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization
por: Sazgary, Lorraine, et al.
Publicado: (2021)

Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
por: Raiden, Silvina, et al.
Publicado: (2021)

Evidence of Pulmonary Hypertension after SARS-CoV-2 Infection in Subjects without Previous Significant Cardiovascular Pathology
por: Tudoran, Cristina, et al.
Publicado: (2021)

Post‐Covid‐19‐vaccination adverse events and healthcare utilization among individuals with or without previous SARS‐CoV‐2 infection
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022)

Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination
por: Suryawanshi, Rahul K., et al.
Publicado: (2023)

Immune Response to SARS-CoV-2 Vaccines
por: Bellamkonda, Navya, et al.
Publicado: (2022)

Impact of Obesity on Vaccination to SARS-CoV-2
por: Nasr, Michaella-Jana C., et al.
Publicado: (2022)

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
por: Hall, Victoria, et al.
Publicado: (2022)

Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers?
por: Pean De Ponfilly, G., et al.
Publicado: (2021)

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
por: Sano, Kaori, et al.
Publicado: (2022)

Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines
por: Wang, Jing, et al.
Publicado: (2023)

SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses
por: Suhandynata, Raymond T., et al.
Publicado: (2021)

SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses
por: Suhandynata, Raymond T, et al.
Publicado: (2021)

Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases
por: Oliosi, E., et al.
Publicado: (2023)

Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
por: Yue, Can, et al.
Publicado: (2023)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Specific T-Cell Immune Response to SARS-CoV-2 Spike Protein over Time in Naïve and SARS-CoV-2 Previously Infected Subjects Vaccinated with BTN162b2
por: Vega-Magaña, Natali, et al.
Publicado: (2022)

Late Hepatitis B reactivation after treatment with rituximab
por: Pereira, Sara Lacerda, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 Infection in a Sample of Health Workers in Two Health Departments of the Valencian Community in Spain
por: Rodríguez de Limia Ramírez, Kenan, et al.
Publicado: (2021)

Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers
por: Soysal, Ahmet, et al.
Publicado: (2021)

Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
por: Ekström, Nina, et al.
Publicado: (2022)

Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department
por: Beck, Evan J., et al.
Publicado: (2022)

COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients
por: Shahid, Zainab, et al.
Publicado: (2023)

Humoral immunity induced by mRNA COVID-19 vaccines in Nursing Home Residents previously infected with SARS-CoV-2
por: Fedele, Giorgio, et al.
Publicado: (2022)

Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua
por: Maier, Hannah E., et al.
Publicado: (2022)

Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination
por: van Dam, Koos P. J., et al.
Publicado: (2022)

Immunity to SARS‐CoV‐2 induced by infection or vaccination
por: Castro Dopico, Xaquin, et al.
Publicado: (2021)

Immune imprinting and SARS-CoV-2 vaccine design
por: Wheatley, Adam K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_abpr5saa9s46f09v9lc557eha8